FAK signaling in cardiac growth and hypertrophy

心脏生长和肥大中的 FAK 信号传导

基本信息

  • 批准号:
    7078577
  • 负责人:
  • 金额:
    $ 31.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-15 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recent genetic evidence indicates that the integrin class of fibronectin-binding adhesion receptors (5E1 and others) can regulate both the form and function of the heart. Integrin ligation drives recruitment of a number of structural and signaling molecules to the ventral plasma membrane collectively termed a "focal adhesion" which serves to link the force-generating actin cytoskeleton inside the cell to the extracellular matrix (ECM), and to coordinate activation of downstream signaling pathways. The non-receptor tyrosine kinase, Focal Adhesion Kinase (FAK) is strongly activated by both integrins and growth factors, and is a likely candidate to integrate downstream signals from these diverse pathways during growth and development. Indeed, germline deletion of FAK results in mesodermal defects and embryonic lethality between E7.5-10 similar to the phenotype observed in both fibronectin-, and D5-null mice. Although a direct role for FAK in cardiac development has yet to be examined, hearts from FAK-null embryos revealed a lack of separate mesocardial and endocardial layers, indicative of a defect in cardiomyocyte maturation. Interestingly, recent work by our group and others clearly indicate that FAK is activated in cultured cardiomyocytes by a variety of hypertrophic stimuli including, phenylephrine (PE), endothelin I (ET-1), angiotensin II (AII), and hypo-osmotic stress, and that increased cardiac FAK activity is observed in vivo in hypertrophic hearts. The idea that FAK activation plays a direct role in the development of cardiomyocyte hypertrophy is evident from our seminal findings that the activation of FAK is required for PE-stimulated hypertrophy of cultured cells and similar findings from others that FAK is required for maximal ET-1 and stretch-induced hypertrophy in vitro. The experimental goals of this proposal are to test the hypothesis that FAK regulates cardiac development and pathological hypertrophy in vivo and to identify the FAK-dependent signaling pathways involved in these processes. We will generate genetically modified mice in which FAK will be deleted in a temporal and cardiac-restricted fashion using Cre/LoxP technology to examine a functional role for FAK in cardiac growth. We will also establish a cardiac cell culture model to identify FAK-dependent signals and target genes that are differentially regulated by hypertrophic stimuli.
描述(由申请人提供):最近的遗传证据表明,纤维连接蛋白结合粘附受体(5E1和其他)的整合素类可以调节心脏的形态和功能。整合素连接驱动许多结构和信号分子聚集到腹侧质膜,统称为“局灶黏附”,用于将细胞内产生力的肌动蛋白细胞骨架与细胞外基质(ECM)连接起来,并协调下游信号通路的激活。非受体酪氨酸激酶,Focal Adhesion kinase (FAK)被整合素和生长因子强烈激活,并且可能在生长和发育过程中整合来自这些不同途径的下游信号。事实上,FAK的种系缺失导致E7.5-10之间的中胚层缺陷和胚胎致死,这与在纤维连接蛋白缺失和d5缺失小鼠中观察到的表型相似。尽管FAK在心脏发育中的直接作用尚未被研究,但来自无FAK胚胎的心脏显示缺乏独立的心内膜和心内膜,这表明心肌细胞成熟存在缺陷。有趣的是,我们小组和其他人最近的工作清楚地表明,FAK在培养的心肌细胞中被各种肥厚性刺激激活,包括苯肾上腺素(PE)、内皮素I (ET-1)、血管紧张素II (AII)和低渗透应激,并且在肥厚性心脏中观察到心脏FAK活性的增加。FAK激活在心肌细胞肥大的发展中起直接作用的观点从我们的开创性发现中得到了证明,即FAK的激活是pe刺激的培养细胞肥大所必需的,以及其他人的类似发现,即FAK是体外最大ET-1和拉伸诱导的肥大所必需的。本研究的实验目的是验证FAK在体内调节心脏发育和病理性肥厚的假设,并确定参与这些过程的FAK依赖性信号通路。我们将使用Cre/LoxP技术产生转基因小鼠,其中FAK将以时间和心脏受限的方式被删除,以检查FAK在心脏生长中的功能作用。我们还将建立心脏细胞培养模型,以鉴定受肥厚刺激差异调节的fak依赖性信号和靶基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joan M Taylor其他文献

Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement
粘着斑激酶:粘着斑动力学和细胞运动的调节剂
  • DOI:
    10.1038/sj.onc.1203877
  • 发表时间:
    2000-11-20
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    J Thomas Parsons;Karen H Martin;Jill K Slack;Joan M Taylor;Scott A Weed
  • 通讯作者:
    Scott A Weed

Joan M Taylor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joan M Taylor', 18)}}的其他基金

Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1
RhoGAP GRAF1 对心肌细胞线粒体自噬的分子控制
  • 批准号:
    10521295
  • 财政年份:
    2019
  • 资助金额:
    $ 31.91万
  • 项目类别:
Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1
RhoGAP GRAF1 对心肌细胞线粒体自噬的分子控制
  • 批准号:
    10311519
  • 财政年份:
    2019
  • 资助金额:
    $ 31.91万
  • 项目类别:
Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1
RhoGAP GRAF1 对心肌细胞线粒体自噬的分子控制
  • 批准号:
    9885284
  • 财政年份:
    2019
  • 资助金额:
    $ 31.91万
  • 项目类别:
Smooth muscle adhesion and plasticity in coronary and outflow tract development
冠状动脉和流出道发育中的平滑肌粘附和可塑性
  • 批准号:
    8440760
  • 财政年份:
    2010
  • 资助金额:
    $ 31.91万
  • 项目类别:
Smooth muscle adhesion and plasticity in coronary and outflow tract development
冠状动脉和流出道发育中的平滑肌粘附和可塑性
  • 批准号:
    8234079
  • 财政年份:
    2010
  • 资助金额:
    $ 31.91万
  • 项目类别:
Control of adhesion-dependent SMC plasticity during coronary and outflow tract de
冠状动脉和流出道脱皮过程中粘附依赖性 SMC 可塑性的控制
  • 批准号:
    7866759
  • 财政年份:
    2010
  • 资助金额:
    $ 31.91万
  • 项目类别:
Control of adhesion-dependent SMC plasticity during coronary and outflow tract de
冠状动脉和流出道脱皮过程中粘附依赖性 SMC 可塑性的控制
  • 批准号:
    8039991
  • 财政年份:
    2010
  • 资助金额:
    $ 31.91万
  • 项目类别:
FAK signaling in cardiac growth and hypertrophy
心脏生长和肥大中的 FAK 信号传导
  • 批准号:
    7234008
  • 财政年份:
    2005
  • 资助金额:
    $ 31.91万
  • 项目类别:
FAK Signaling in cardiac growth and hypertrophy
心脏生长和肥大中的 FAK 信号传导
  • 批准号:
    7785173
  • 财政年份:
    2005
  • 资助金额:
    $ 31.91万
  • 项目类别:
FAK signaling in cardiac growth and hypertrophy
心脏生长和肥大中的 FAK 信号传导
  • 批准号:
    7436305
  • 财政年份:
    2005
  • 资助金额:
    $ 31.91万
  • 项目类别:

相似海外基金

Modeling the spatiotemporal properties of crosstalk between RYR-mediated and IP3R-mediated calcium signaling in cardiac myocytes
模拟心肌细胞中 RYR 介导和 IP3R 介导的钙信号传导之间串扰的时空特性
  • 批准号:
    10701689
  • 财政年份:
    2022
  • 资助金额:
    $ 31.91万
  • 项目类别:
Understanding the mechanism why cardiac myocytes resist Myc-induced proliferation
了解心肌细胞抵抗 Myc 诱导的增殖的机制
  • 批准号:
    21K08854
  • 财政年份:
    2021
  • 资助金额:
    $ 31.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating molecular mechanisms of magnesium regulation to protect cardiac myocytes against life-style related diseases
阐明镁调节保护心肌细胞免受生活方式相关疾病的分子机制
  • 批准号:
    20K11518
  • 财政年份:
    2020
  • 资助金额:
    $ 31.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytes
克氏锥虫感染心肌细胞中宿主寄生虫的脂质代谢
  • 批准号:
    10058037
  • 财政年份:
    2020
  • 资助金额:
    $ 31.91万
  • 项目类别:
Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytes
克氏锥虫感染心肌细胞中宿主寄生虫的脂质代谢
  • 批准号:
    10249356
  • 财政年份:
    2020
  • 资助金额:
    $ 31.91万
  • 项目类别:
A System to Optically Determine the Absolute Membrane Potential in Human iPSCD Cardiac Myocytes
光学测定人 iPSCD 心肌细胞绝对膜电位的系统
  • 批准号:
    10081467
  • 财政年份:
    2020
  • 资助金额:
    $ 31.91万
  • 项目类别:
cAMP Compartmentation in Cardiac Myocytes
心肌细胞中的 cAMP 区室
  • 批准号:
    10321915
  • 财政年份:
    2019
  • 资助金额:
    $ 31.91万
  • 项目类别:
cAMP Compartmentation in Cardiac Myocytes
心肌细胞中的 cAMP 区室
  • 批准号:
    10079026
  • 财政年份:
    2019
  • 资助金额:
    $ 31.91万
  • 项目类别:
Intramyocardial magnetic targeting of cardiac myocytes
心肌细胞的心肌内磁靶向
  • 批准号:
    405831333
  • 财政年份:
    2018
  • 资助金额:
    $ 31.91万
  • 项目类别:
    Research Grants
Translational research for the development of novel heart failure therapy that targets signaling pathway in cardiac myocytes
开发针对心肌细胞信号通路的新型心力衰竭疗法的转化研究
  • 批准号:
    18K08121
  • 财政年份:
    2018
  • 资助金额:
    $ 31.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了